Mammalian target of rapamycin (mTOR) kinase, mTORC1, and mTORC2 complexes are considered critical drivers of cancer drug resistance that integrate signaling pathways driving cell metabolism and growth [140,141]. The gene discussed is MTOR; the disease is cancer.